Company intelligence / Profile preview

Wynnefield Capital

New York, New York, United States

Ownership: Private
Development stage: Other

Overview

Wynnefield Capital is a New York-based hedge fund founded in 1992, specializing in small-cap value and special situations investments. It is not a biotech, pharmaceutical, CRO, or CMO company, nor does it develop drugs or therapies. Instead, it invests in publicly traded companies, some of which may be in the life sciences sector, but Wynnefield itself does not engage in research, development, or commercialization of health products.

Industry: Investors

Beyond the preview

Go deeper on Wynnefield Capital.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wynnefield Capital.

Explore the full profile